Sireesh Appajosyula, CEO, Director at Canton Strategic Holdings, holds 1.25M shares in Hepion Pharmaceuticals (Ticker: HEPA), holds 64.87K shares in Canton Strategic Holdings (Ticker: CNTN). Most recently, Sireesh Appajosyula Bought ― shares of Hepion Pharmaceuticals on Apr 27, 2026 for an estimated value of $50.00K.
What is the percentage of profitable transactions made by Sireesh Appajosyula?
The percentage of profitable transactions made by Sireesh Appajosyula is 75%.
What is the average return per transaction made by Sireesh Appajosyula?
The average return per transaction made by Sireesh Appajosyula is 60.20%.
What stocks does Sireesh Appajosyula hold?
Sireesh Appajosyula holds: CNTN, HEPA stocks.
What was Sireesh Appajosyula’s latest transaction?
Sireesh Appajosyula latest transaction was an Informative Buy of $50.00K.
What was Sireesh Appajosyula's most profitable transaction?
Sireesh Appajosyula’s most profitable transaction was an Informative Buy of CNTN stock on June 23, 2025. The return on the trade was 146.50%.
What is Sireesh Appajosyula's role in Canton Strategic Holdings?
Sireesh Appajosyula's role in Canton Strategic Holdings is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.